Opinion: Stop sidelining science. Bring back federal scientific advisory committees
In a move touted as “improving the utility of federal advisory committees,” President Trump signed…
Author: STAT
STAT+: Democrats have their best shot yet at letting Medicare negotiate drug prices — but it’s still not a done deal
WASHINGTON — Democrats have their best shot in more than a decade to deliver on…
For people with type 1 diabetes, CDC guidelines for Covid-19 vaccine priority are puzzling
Laura Woerner has diligently managed her type 1 diabetes since she was diagnosed at age…
Opinion: We lost to SARS-CoV-2 in 2020. We can defeat B-117 in 2021
We are barely a week into 2021 and already there are urgent warnings about a…
Opinion: Even during a pandemic, hospitals must make family visits and communication the standard of care
Since the start of the pandemic, nearly 340,000 Americans have died of Covid-19, many of…
Most patients hospitalized for Covid-19 still have symptoms six months later, China study finds
Three-quarters of Covid-19 patients still have at least one symptom six months after first falling…
STAT+: Tennessee to become the first state to run a closed Medicaid drug formulary
In a first-of-its-kind move, the Trump administration will allow Tennessee officials to restrict medicines covered…
STAT+: FDA advisory panel meetings became ‘rarer and tougher’ in 2020
Among the myriad changes wrought by the Covid-19 pandemic, Food and Drug Administration advisory committee…
Biden’s plan to end policy of keeping Covid vaccine doses in reserve is the first step in a difficult journey
The transition team of President-elect Joseph Biden has taken its first step to re-examine the…
STAT+: ‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans
It’s tempting to see Haven as another casualty of entrenched interests in American medicine. But…
STAT+: Pharmalittle: Pfizer-BioNTech vaccine seems to work against Covid-19 mutation; Sarepta gene therapy shows mixed results
And so, another working week will soon draw to a close. Not a moment too…
Pfizer-BioNTech vaccine not affected by mutation seen in contagious coronavirus variant, study indicates
A mutation found in fast-spreading coronavirus variants does not negate the Covid-19 vaccine from Pfizer…
Opinion: Mother Nature is not ‘the ultimate bioterrorist’
Despite the menacing track record of emerging pathogens, “Mother Nature is the world’s worst bioterrorist,”…
Opinion: Even in a virtual JPM week, we need to maintain the relationship glue that keeps the biotech industry strong
Every January, the week of the annual J.P. Morgan Healthcare Conference (JPM week) is a…
‘A supreme form of advocacy’: When finding a psychiatric bed seems impossible, one state’s patients have a partner
Hallie-Beth Hollister is a master at cold calling. She has to be. She and a…
Listen: Biden’s plans for biopharma, a CES preview, & the next phase of the pandemic
What does a Democratic Senate portend for the drug industry? Is software eating health care?…
STAT+: Sarepta gene therapy for Duchenne muscular dystrophy stumbles with failed study outcome
Sarepta Therapeutics on Thursday announced mixed results from the first randomized clinical trial of its…
STAT+: With success in vaccines, scientists try to turn mRNA against autoimmune diseases
The technology used in a pair of pioneering Covid-19 vaccines works by effectively revving up…
STAT+: With biotech funding at ‘all-time high,’ Scorpion scoops up $162 million
Just over two months after announcing its debut with $108 million in funding, Boston startup…
STAT+: Pharmalittle: Slaoui to become Warp Speed consultant; CureVac teams with Bayer for Covid-19 vaccine help
Good morning, everyone, and how are you today? Like many others, we are forging ahead…
Serial biotech entrepreneur John Hood raises $62 million for company aimed at deadly lung disease
John Hood is at it again. In 2016, Hood started a company, Impact BioMedicines, around…
STAT+: Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat
An arcane regulatory term known as skinny labeling may have a funny ring to it,…
Opinion: Along with vaccine rollouts, the U.S. needs a National Hi-Fi Mask Initiative
Though the first Covid-19 vaccines are now being given to health care workers, other frontline…
Opinion: Wastewater-based epidemiology: a 20-year journey may pay off for Covid-19
When I entered public service in 1991 as a research scientist with the Environmental Protection…
Scientists are monitoring a coronavirus mutation that could affect the strength of vaccines
As scientists try to track the spread of a new, more infectious coronavirus variant around…
Operation Warp Speed’s Moncef Slaoui will stay on as a consultant for Biden
WASHINGTON — Moncef Slaoui, the controversial head of Operation Warp Speed, will serve as a…
CDC reports more allergic reactions to Covid-19 vaccines, but cases remain few
Twenty-nine people in the United States have developed anaphylaxis after being vaccinated against Covid-19 since…
CRISPR cures progeria in mice, raising hope for one-time therapy for a disease that causes rapid aging
Biologists tend not to discuss experimental results on a handful of cells and a single…
STAT+: Pharmalittle: U.S. speeds plan for pharmacies to give Covid-19 shots; European agency okays Moderna vaccine
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle…
STAT+: Siddhartha Mukherjee forms his second biotech company, focused on using cell therapy for solid tumors
Almost five years after debuting his first biotech company, noted writer and oncologist Siddhartha Mukherjee…
Opinion: The FDA needs to apply its Covid-19 flexibility to pediatric cancer
One of the few bright spots in the Covid-19 pandemic has been the swift development…
Opinion: 5 scenarios for containing the Covid-19 pandemic and returning to a ‘new normal’
“When will this pandemic be over so we can return to normal life and an…
For people with OCD — and fearful of germs — the pandemic is upending years of therapy
Long before the pandemic arrived, Renée battled intense fears of getting sick from daily life….
Messonnier: The slow vaccine rollout should speed up ‘pretty massively’ in coming weeks
Nancy Messonnier, a top federal health official involved in the distribution of Covid-19 vaccines, predicted…
Opinion: Doctors on social media are being cyberbullied and sexually harassed. It’s time to change that
As women in medicine who use social media to advocate for public health and social…
STAT+: STAT+ Conversations: A (continued) conversation on the Covid-19 vaccine rollout
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET. …
STAT+: Pharmalittle: FDA warns against changing Covid-19 vaccine dosing; Moderna to increase vaccine production
Hello, everyone, and how are you today? We are doing just fine, thank you, as…
STAT+: Inside the collapse of a disrupter: How Haven’s high hopes of redefining health care came to a crashing halt
The dissolution of Haven marks one of the most stunning collapses in modern health care…
Opinion: Proposed new rules for a J-1 visa will hinder America’s fight against Covid-19
As Covid-19 infections once again surge across the United States, one of the biggest obstacles…
Opinion: Decades of basic research paved the way for today’s ‘warp speed’ Covid-19 vaccines
The emergency use authorizations of mRNA vaccines by Pfizer/BioNTech and Moderna and the likely gradual…
STAT+: Triplet Therapeutics and three other startups got venture funding a year ago. Where are they now?
In a typical year, a biotech startup might hope to raise enough money to keep…
STAT+: The biotech scorecard for the first quarter: 17 stock-moving events to watch
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first…
Biden’s appointment of a health disparities adviser is historic. But her impact will depend on how the White House empowers her
WASHINGTON — President-elect Biden’s slate of high-level health care appointments includes an unprecedented selection: The…
STAT+: Pharma rings in the new year with 5% price hikes on hundreds of medicines
When it comes to prescription drug prices, what goes up often continues to go up…
Haven, ambitious health venture backed by Amazon, to shut down
After a tumultuous three years marked by halting progress and high rates of employee turnover,…
STAT+: HHS rebukes drug makers for curtailing discounts to hospitals that serve low-income communities
After months of controversy, the Department of Health and Human Services issued a stern rebuke…
Opinion: Instead of debating ‘first-shot’ vs. ‘set-aside’ vaccine approaches, hospitals’ study should compare them
The FDA authorizations of two Covid-19 vaccines so far specify two-shot regimens, spaced three weeks…
STAT+: Pharmalittle: U.S. considers giving half-doses of Moderna vaccine; Americans may not get AstraZeneca shot until April
Good morning, everyone, and nice to see you after an extended holiday break. We hope…
How it started: A Q&A with Helen Branswell, one year after Covid-19 became a full-time job
Before the virus that causes Covid-19 had a name — before Covid-19 itself had a name…
STAT+: The health tech tracker for the first quarter: 13 important events to watch
It will be a quarter unlike any other in recent memory for the health tech…